Work

Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors

Year: 2011

Type: article

Study design: Observational Study

Source: Gastroenterology

DOI: 10.1053/j.gastro.2011.12.005

Authors: Jesper B. Andersen, Bart Spee, Boris R. Blechacz, Itzhak Avital, Mina Komuta, Andrew Barbour, Elizabeth A. Conner, Matthew C. Gillen, Tania Roskams, Lewis R. Roberts, Valentina M. Factor, Snorri S. Thorgeirsson

Institutions: National Institutes of Health, KU Leuven, Mayo Clinic, The University of Queensland

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Mayo Clinic, Sundhed og Sygdom, Det Frie Forskningsråd, National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G3007227322, G311967391, G3551906317, G601308626, G7162950184, G8361455225, Molecular Pathogenesis of Hepatocellular Carcinoma, G9000043042, G9000053734, G9000226708, G9000257663

OpenAlex ID: W2085417547

FWCI: 22.55

Cites: 31

Cited by: 552

Related to: 10